Is Gaudium IVF and Women Health Ltd (GAUDIUMIVF) a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Gaudium IVF and Women Health Ltd is a average quality company .

Is Gaudium IVF and Women Health Ltd (GAUDIUMIVF) undervalued or overvalued?

The key valuation ratios of Gaudium IVF and Women Health Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone .

What is Gaudium IVF and Women Health Ltd (GAUDIUMIVF) share price return in the past 10 years?

Data is not available for this company

Is Gaudium IVF and Women Health Ltd (GAUDIUMIVF) a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Gaudium IVF and Women Health Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

What is the share price of Gaudium IVF and Women Health Ltd (GAUDIUMIVF)?

Company share prices are keep on changing according to the market conditions. The current trading price of Gaudium IVF and Women Health Ltd (GAUDIUMIVF) on 17-Apr-2026 16:59:59 at 16:59 is 97.22.

What is the P/E ratio of Gaudium IVF and Women Health?

The latest standalone P/E ratio of Gaudium IVF and Women Health as of 17-Apr-2026 is 38.07.

What is the P/B ratio of Gaudium IVF and Women Health Ltd (GAUDIUMIVF)?

The latest standalone P/B ratio of Gaudium IVF and Women Health Ltd (GAUDIUMIVF) as of 17-Apr-2026 is 3.39.

What is the 52-week high and low of Gaudium IVF and Women Health Ltd (GAUDIUMIVF)?

The 52-week high of Gaudium IVF and Women Health Ltd (GAUDIUMIVF) is Rs. 108.00 and the 52-week low is Rs. 69.50.

Gaudium IVF and Women Health Ltd (GAUDIUMIVF) Share Analysis – Quality, Pipeline & Valuation Zone & DeciZen Rating

Name: Gaudium IVF and Women Health Ltd (GAUDIUMIVF)
Brand: Gaudium IVF and Women Health

Gaudium IVF and Women Health Ltd (GAUDIUMIVF) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

Gaudium IVF and Women Health Ltd (GAUDIUMIVF)

BSE: 544709 NSE: GAUDIUMIVF

Key Metrics

Market Cap

₹708 Cr.

P/E Ratio

38.07

Price to Book (P/B)

3.39

Price to Sales (P/S)

11.99

EV/EBITDA

25.41

Return on Capital Employed (ROCE)

49.31%

Current Price

₹97.2

Return on Equity (ROE)

51.56%

Return on Assets (ROA)

29.56%

Operating Profit Margin

47.6%

Net Profit Margin

31.5%

Gross Profit Margin

45.3%

Book Value per Share

₹28.7

Sales Growth (YoY)

28.43%

Sales Growth (3 Years)

17.34%

Operating Profit Growth (1 Year)

48.76%

Operating Profit Growth (3 Years)

26.75%

Net Profit Growth (1 Year)

87.21%

52-Week Low / High

₹70 / 108

Net Profit Growth (3 Years)

-87.31%

Dividend Yield

0.00%

Promoter Holding

71.29%

Pledged shares (%)
of Promoter's holding (%)

0.00%

Check Before You Invest

Q.1 Revenue growth of Gaudium IVF and Women Health Ltd?

Gaudium IVF and Women Health Ltd revenue growth is 28.4% for FY-2025 , which is above its 5 year CAGR of 0% , indicating faster growth.

Q.1 Promoter shareholding and pledge status of Gaudium IVF and Women Health Ltd?

Promoters hold 71.29% of the Gaudium IVF and Women Health Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Q.1 Revenue growth of Gaudium IVF and Women Health Ltd vs industry peers?

Gaudium IVF and Women Health Ltd revenue CAGR is 0.00% , compared to the industry median CAGR of 1.49% , indicating stable growth and maintaining its market share.

Q.1 Which industry/sub-sector does Gaudium IVF and Women Health Ltd belong to?

Gaudium IVF and Women Health Ltd belongs to the Healthcare sector, operating specifically within the Hospital & Healthcare Services segment.

Q.1 Stock return of Gaudium IVF and Women Health Ltd over the last decade?

Over the last - year(s), the stock has delivered a CAGR of N/A% based on the current price.

DeciZen - make an informed investing decision on Gaudium IVF & Women

Based on:

Data

Overall Rating ⓘ
Login to view analysis.

1. Quality

2. Valuation

3. Price Trend

Gaudium IVF and Women Health stock performance

Key Ratios

Is Gaudium IVF and Women Health Ltd an attractive stock to invest in?

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	82.7%	76.5%	45.4%	49.3%	-
Value Creation Index ⓘ	4.9	4.5	2.2	2.5	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	36.5	44	45.9	59	59
Sales YoY Gr.	-	20.5%	4.4%	28.4%	-
Adj EPS ⓘ	1.5	2.2	1.6	3	2.6
YoY Gr.	-	46%	-25%	87%	-
BVPS (₹) ⓘ	1.6	3.7	4.3	7.4	28.7
Adj Net Profit ⓘ	9.1	13.3	9.9	18.6	19
Cash Flow from Ops. ⓘ	0	24	3.5	8.4	-
Debt/CF from Ops. ⓘ	0	0.4	4.5	2.2	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	NA	NA	17.3%	28.4%
Adj EPS ⓘ	NA	NA	27%	87%
BVPSⓘ	NA	NA	68%	70.5%
Share Price	-	-	-	-

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	95.1	81.9	40.1	51.6	14.1
Op. Profit Mgn % ⓘ	37.8	44.9	41.1	47.6	40.6
Net Profit Mgn % ⓘ	24.9	30.1	21.6	31.5	31.5
Debt to Equity ⓘ	0.6	0.4	0.6	0.4	-
Working Cap Days ⓘ	0	75	91	175	0
Cash Conv. Cycle ⓘ	0	13	49	107	0

Recent Performance Summary

Latest Financials

	Standalone	Consolidated
TTM EPS (₹)	2.6	2.6
TTM Sales (₹ Cr.)	59	70.7
BVPS (₹) ⓘ	28.7	28.9
Reserves (₹ Cr.) ⓘ	172	174
P/BV ⓘ	3.39	3.37
PE ⓘ	38.07	37.00

From the Market
52 Week Low / High (₹)	69.50 / 108.00
All Time Low / High (₹)	69.50 / 106.70
Market Cap (₹ Cr.)	708
Equity (₹ Cr.)	36.4
Face Value (₹)	5
Industry PE ⓘ	86.1

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Gaudium IVF & Women - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Key Ratios

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'22	Mar'23	Mar'24	Mar'25
Sales	37	44	46	59
Operating Expenses ⓘ +	23	24	27	31
Manufacturing Costs	3	5	6	6
Material Costs	4	5	4	5
Employee Cost	4	6	6	7
Other Costs ⓘ	11	8	10	12
Operating Profit ⓘ	14	20	19	28
Operating Profit Margin (%)	37.8%	44.9%	41.1%	47.6%
Other Income ⓘ +	0	0	0	0
Exceptional Items ⓘ	0	0	0	0
Interest ⓘ	1	0	1	2
Depreciation ⓘ	1	1	2	2
Profit Before Tax ⓘ	12	18	16	25
Tax ⓘ	3	5	6	6
Profit After Tax	9	13	10	19
PAT Margin (%)	24.9%	30.1%	21.6%	31.5%
Adjusted EPS (₹)	1.5	2.2	1.6	3.0
Dividend Payout Ratio (%)	0%	48%	0%	0%

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	10	23	27	45
Share Capital ⓘ	1	1	1	31
Reserves ⓘ	9	22	26	15
Debt +	6	10	16	19
Long Term Debt	2	2	2	2
Short Term Debt	3	8	14	17
Minority Interest	0	0	0	0
Trade Payables	1	1	1	1
Others Liabilities ⓘ	4	2	7	9
Total Liabilities ⓘ	21	35	51	75
Fixed Assets
Net Fixed Assets ⓘ +	4	16	18	18
Gross Block	7	20	20	22
Accumulated Depreciation	3	4	2	4
CWIP ⓘ	0	0	0	7
Investments ⓘ	0	1	1	6
Inventories	0	1	2	3
Trade Receivables	6	1	14	24
Cash Equivalents	2	15	12	7
Others Assets ⓘ	8	1	4	11
Total Assets ⓘ	21	35	51	75

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	24	3	8
PBT ⓘ	18	16	25
Adjustment ⓘ	2	3	3
Changes in Working Capital ⓘ	9	-14	-15
Tax Paid ⓘ	-5	-2	-5
Cash Flow From Investing Activity ⓘ +	-14	-5	-15
Capex	-13	-3	-9
Net Investments	0	-0	-5
Others ⓘ	-1	-2	-1
Cash Flow From Financing Activity ⓘ +	4	-1	2
Net Proceeds from Shares ⓘ	0	0	0
Net Proceeds from Borrowing ⓘ	-0	-0	-0
Interest Paid ⓘ	-0	-1	-1
Dividend Paid ⓘ	0	-6	0
Others ⓘ	4	6	3
Net Cash Flow ⓘ	13	-3	-5

Finance Ratio

PARTICULARS	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	95.13	81.88	40.12	51.56
ROCE (%)	82.7	76.47	45.41	49.31
Asset Turnover Ratio	1.77	1.58	1.07	0.94
PAT to CFO Conversion(x)	0	1.85	0.3	0.42
Working Capital Days
Receivable Days	63	30	58	115
Inventory Days	3	7	12	13
Payable Days	114	91	91	83

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Gaudium IVF and Women Health Ltd FAQs

The current trading price of Gaudium IVF & Women on 17-Apr-2026 16:59 is ₹97.22.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 16-Apr-2026 the market cap of Gaudium IVF & Women stood at ₹707.6 Cr

The latest P/E ratio of Gaudium IVF & Women as of 16-Apr-2026 is 38.07.

The latest P/B ratio of Gaudium IVF & Women as of 16-Apr-2026 is 3.39.

The 52-week high of Gaudium IVF & Women is ₹108.0 and the 52-week low is ₹69.50.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Gaudium IVF & Women is ₹59.00 ( Cr.) .

About Gaudium IVF and Women Health Ltd

Gaudium IVF and Women Health was originally incorporated in the name of ‘Gaudium IVF and Women Health Private Limited’ as a private limited company on March 24, 2015. Subsequently, the company was converted from a private limited company into a public limited company pursuant to a special resolution passed in the extraordinary general meeting of the shareholders held on September 28, 2024 and consequently, the name of the company was changed to ‘Gaudium IVF and Women Health Limited’.

The company is engaged in IVF (In vitro fertilization) treatment in India and has grown into several states with Hub and spoke model over the years. The company has patients from different countries such as Canada, United Kingdom, United State, Kenya, South Africa and Oman. The company’s Main centers (Hubs) are located in major cities to cater potential locations across India.

The company offers a complete array of specialized fertility and reproductive health services. Its advance treatments include In Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), Intrauterine Insemination (IUI), and ovulation induction, all its treatments are carefully designed to address a variety of infertility challenges for both male and female. The company also offers comprehensive gynaecological care, including PCOD/PCOS and endometriosis. Further, high-risk pregnancy management is provided for women with complex fertility histories or health conditions. The wellness aspect includes fertility wellness programs, offering nutritional counselling and psychological support to ensure holistic care for couples undergoing treatments.

Business area of the company

Services of the company

Fertility Treatment

IVF treatment, or in vitro fertilization
Intrauterine Insemination (IUI)
Intracytoplasmic Sperm Injection (ICSI)
Polycystic Ovarian Syndrome (PCOS), also known as polycystic ovarian disease (PCOD)
Male Infertility
Endometriosis Treatment
Ovulation Induction (OI)
Laser Assisted Embryo Implantation
Infertility Surgeries
Surrogacy

Hospital Facility

Pharmacy service

Awards, accreditations and recognition

2016: Asia's Greatest Brand.
2018: Symbol of Brand Excellence Award.
2019: India Best Practices Award- IVF Chain Company of the Year.
2022: Highly Prestigious Quality Choice Award.
2023: Holistic Healthcare Brand Leader of the Year.

History and milestones

2015: Incorporation of the company.
2019: The company started Gaudium Hospital.
2021: Acquired the Gaudium IVF & Gynae Solutions, Proprietor Business of Dr. Manika Khanna: Janakpuri Center (opened in 2009), Greater Kailash Center (opened in 2016), Patna Center (opened in 2019).
2021: The company started Mumbai Center (Maharashtra).
2023: Acquired Gaudium Brand.
2023: Acquired 100% shares of Gaudium International Private Limited.
2023: Acquired Gaudium Bawa Ludhiana Center.
2023: The company started Bangalore Centre (Karnataka).
2024: The company started Srinagar Centre (Jammu & Kashmir).
2024: Conversion of company from Private to Public.

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

Build a Stress-Tested Portfolio.

Our Sapphire Advisory uses the ABC Concept to ensure you never have to panic during a market correction.

Core Stocks

STABILITY

Booster Stocks

GROWTH

Amplifier Stocks

ASYMMETRY

● Conflict-Free ● SEBI Registered ● 15Y+ Track Record

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Gaudium IVF and Women Health Ltd (GAUDIUMIVF) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

Gaudium IVF & Women Share Price